PO.CL12.02 · 临床研究
Translational Biomarkers and Emerging Molecular Approaches
-
7896 · PDF 使用连接IRDye700Dx的抗CEA抗体诱导靶向细胞毒性和免疫原性细胞死亡 Induction of targeted-cytoxicity and immunogenic cell death using an anti-CEA antibody linked to IRDye700Dx Simran Mehta, Jitender Jitender, Teresa Hong, Michael Bouvet, John E. Shively, Paul J. Yazaki, Thinzar Min Lwin
- 7897 7897 新型Rho-GTP酶调控蛋白基因家族变异在急性髓系白血病(AML)患者(pts)中频发,并与不良生存相关 Novel Rho-GTPase regulatory protein gene family variants are frequent and associate with poor survival in patients (pts) with acute myeloid leukemia (AML) Ethan Hamp, Lorenz Oelschläger, Bailee N. Kain, Deedra Nicolet, Krzysztof Mrozek, Katherine E. Miller, Audrey Bollas, Michael C. Walker, Christopher J. Walker, Jill Buss, Andrea Laganson, Andrew J. Carroll, William G. Blum, Bayard L. Powell, Geoffrey L. Uy, Wendy Stock, Marina Y. Konopleva, Richard M. Stone, John C. Byrd, Martin Carroll, Tanmoy Sarkar, Akmaljon Salimov, Benjamin J. Kelly, Electra D. Paskett, Jesse J. Plascak, Shannon McWeeney, Jeffrey W. Tyner, Jeffery Klco, Nathan Salomonis, H. Leighton Grimes, Elaine R. Mardis, Ann-Kathrin Eisfeld
- 7898 7898 HIF-2alpha抑制剂casdatifan(Cas)在ARC-20临床研究中透明细胞肾细胞癌(ccRCC)患者各分子亚型中的临床获益 Clinical benefit of the HIF-2alpha inhibitor casdatifan (Cas) across molecular subtypes in clear cell renal cell carcinoma (ccRCC) patients from the ARC-20 Clinical Study Benjamin Weeder, Yinghui Guan, Jaskirat Singh, Brian Rini, Toni K. Choueiri, Angelo Kaplan, Omar Kabbarah, Soonweng Cho
- 7899 7899 BGB-21447,一种新一代Bcl-2抑制剂,在临床前研究中于Bcl-2过表达的B细胞非霍奇金淋巴瘤(NHL)中显示出高潜力 BGB-21447, a next generation Bcl-2 inhibitor, shows high potential in Bcl-2 overexpressing B cell non-Hodgkin lymphomas (NHL) cancers in preclinical studies Haitao Wang, Lin Li, Yiwen Wang, Weiwei Song, Shuang Peng, Sijia Zhai, Ziyu Jia, Peng Chi, Teiko Sumiyoshi, Ting Deng, Yang Liu, Wei Jin, Zhirong Shen
-
7900 · PDF UBQLN4表达升高与肝内胆管癌顺铂耐药的临床意义 Clinical significance of elevated UBQLN4 expression with resistance to cisplatin in intrahepatic cholangiocarcinoma Kodai Abe, Kelly K. Chong, Yuta Abe, Minoru Kitago, Motonori Edanami, Yosuke Uematsu, Yohei Masugi, Akihisa Ueno, Anton Bilchik, Yosef Shiloh, Yuko Kitagawa, Dave Hoon
-
7901 · PDF 采用新型B7-H3靶向超声造影成像进行肾癌早期诊断 Renal cancer early diagnosis using a novel B7-H3 targeted ultrasound contrast imaging Arutselvan Natarajan, Jihye Baek, Ramasamy Paulmurugan, Jeremy Dahl
- 7902 7902 OncoMate MSI Dx分析系统在伴随诊断分类为MSS(非MSI-H)的KEYNOTE-775子宫内膜癌亚组中的分析准确性和临床性能 Analytical accuracy and clinical performance of the OncoMate MSI Dx Analysis System in a subset of KEYNOTE-775 endometrial carcinoma classified as MSS (not MSI-H) by the companion diagnostic Sam Sibley, Matthew Marton, Amy Wehn, Yiwei Zhang, Kathryn Oostdik, Ryan Mordini, Gary Tarpley
-
7903 · PDF MiR-362-3p增强乳腺癌的铂类反应 MiR-362-3p enhances platinum response in breast cancer Zhaoji Liu, Shizhong Ke, Xiaohui Li, Catherine Wu, Madison M. Uyemura, Brian R. Sardella, Erica S. Massicott, Lin Wang, Emily K. Aronson, Dimitra Karagkouni, Nikolas Kalavros, Ioannis S. Vlachos, Felipe Batalini, Cristina S. Bogsan, Jit Kong Cheong, Lihan Zhou, He Cheng, Phillip Munson, Erica L. Mayer, Judy E. Garber, Stuart J. Schnitt, Nadine M. Tung, Andrea L. Kasinski, Frank J. Slack, Gerburg M. Wulf, Yujing J. Heng
-
7904 · PDF Galectin-9作为一种糖修饰佐剂增强Elotuzumab介导的多发性骨髓瘤免疫治疗 Galectin-9 as a glycan-modulating adjuvant to enhance Elotuzumab-mediated immunotherapy in multiple myeloma Rajib Kumar Shil, Guenther Koehne, Charles J. Dimitroff
- 7905 7905 抑制二氢乳清酸脱氢酶(DHODH)并协同靶向ROR1:一种在小细胞肺癌中具有前景的治疗策略 Dihydroorotate dehydrogenase (DHODH) inhibition as a promising therapeutic strategy with synergistic targeting of ROR1 in small cell lung cancer Bahareh Nourmohammadi, Ola A. Elgamal, Sandip Vibhute, Christopher C. Coss, Thomas E. Goodwin, Erin Hertlein, Joseph M. Amann, Ju Hwan Cho, Chad E. Bennett, John C. Byrd, David P. Carbone
-
7906 · PDF 整合多组学分析鉴定出胆管癌中一种免疫治疗易感且与预后相关的亚型 Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma Lu Chen, Xiangdong Tian
- 7907 7907 雌激素受体阳性、HER2低表达乳腺癌的基因组、免疫和临床特征:NextGIM试验最新进展 Genomic, immune, and clinical characterization of estrogen receptor-positive, HER2-low breast cancer: The NextGIM trial latest updates Barbara Cardinali, Alice Stella, Chiara Molinelli, Marco Bruzzone, Yanina Lizet Castillo, Francesca Pitto, Barbara Massa, Simona Pigozzi, Andrea Sciutto, Giorgia Anselmi, Maria Dono, Virna Maltoni, Benedetta Conte, Giulia Buzzatti, Davide Soldato, Gaia Griguolo, Valentina Guarneri, Mario Giuliano, Caterina Marchiò, Fabio Puglisi, Lorenzo Gerratana, Francesca Poggio, Lucia Del Mastro
- 7908 7908 极早发结直肠癌中独特的分子和临床侵袭性:30-39岁与40-49岁患者之间的生存和基因组差异 Distinct molecular and clinical aggressiveness in very early-onset colorectal cancer: Survival and genomic divergence between patients aged 30-39 vs 40-49 years Andrea Pretta, Gaia Rebecchi, Giulia Maddalena, Federica Marmorino, Pina Ziranu, Federica Manoni, Maria Caterina De Grandis, Martina Carullo, Clelia Donisi, Giovanni Randon, Eleonora Perissinotto, Ada Taravella, Vincenzo Nasca, Federica Buggin, Paolo Ciracì, Francesca Bergamo, Chiara Cremolini, Sara Lonardi, Mario Scartozzi, Filippo Pietrantonio
-
7909 · PDF 探索一种LINC00092相关的多组学特征作为结直肠癌中临床可操作的生物标志物 Exploring a LINC00092-associated multiomics signature as a clinically tractable biomarker in colorectal cancer Pankaj Kumar Ahluwalia, Alicia Walker, Sade Logan, Denton Lord, Shamia Jordan, Kimya Jones, Ashis Mondal, Ravindra Kolhe
- 7910 7910 用于原位前列腺癌、膀胱癌、肝癌、胰腺癌和脑癌转化治疗研究的先进临床前癌症模型和成像方案 Advanced preclinical cancer models and imaging protocols for translational treatment studies in orthotopic prostate, bladder, liver, pancreatic and brain cancer Celine Christine Jensen, Emilie Garly, Rikke Stagaard, Michala Nordfalk, Sigrid Cold, Mette Munk Wessel, Tea Kirkegaard Nielsen, Margarete Karg, Natalia Łopuszyńska, Marina Simón Martin, Sara Vangsgaard, Sebastian Gnosa, Ingrid Hunter, Emma Papin, Camilla Malec, Anne Hessellund Langhave, Trine Nielsen, Andreas Kjaer, Esben Christensen, Trine Bjoernbo Engel, Lotte Kellemann, Carsten Haagen Nielsen
-
7911 · PDF 多队列转录组分析鉴定驱动前列腺癌高危生化复发的通路 Multi-cohort transcriptomic profiling identifies pathways driving high-risk biochemical recurrence in prostate cancer Sabrina Yepes-Rodriguez, Rafael Parra-Medina
-
7912 · PDF 一种新型PD-L1 CAL10检测在食管癌中的性能分析 Performance analysis of a novel PD-L1 CAL10 assay in esophageal cancer Ibrahim Abukhiran, Matthew G. Hanna, Dimitrios Korentzelos, Rajiv Dhir, Aatur D. Singhi, Shubham Dayal, Joseph Chiweshe, Xiaozhi Zhou, Robert Monroe, Michelle Wood-Trageser
-
7913 · PDF OXC-101(karonudib)治疗犬淋巴瘤和血管肉瘤:安全性、早期疗效及转化潜力 OXC-101 (karonudib) in canine lymphoma and hemangiosarcoma: Safety, early efficacy, and translational potential Kumar Sanjiv, Sara Saelström, Martin Scobie, Ulrika warpman Berglung, Thomas Helleday, Henrik Rönnberg
-
7914 · PDF 浆细胞样尿路上皮癌的临床前建模以研究癌症机制和治疗反应 Preclinical modeling of plasmacytoid urothelial carcinoma to study cancer mechanisms and therapeutic response Kanisha Kar, Caroline Dickey, William Kim, Kathryn Gessner
-
7915 · PDF 携带KRAS 13D突变的结直肠癌(CRC)的分子图谱 Molecular landscape of colorectal cancer (CRC) with KRAS 13D mutations Masango Samuel, Yuliang Chen, Sarah Castillo, Chenbo Sun, Natalia Ignatenko, Daruka Mahadevan, Ritu Pandey
-
7916 · PDF 肿瘤微环境中的Galectin-2表达:胰腺导管腺癌进展的一条沉默通路 Galectin-2 expression in the tumor microenvironment: A silent pathway of pancreatic ductal adenocarcinoma progression Moacyr Jesus B. Melo Rêgo, Richard Tomasini, Sophie Vasseur, Maira Pitta, Maria Clara P. D. Sampaio, Amanda P. B. Albuquerque, Pascal Finetti, Cláudio Montenegro, Michelly Cristiny Pereira, Michelle Rosa
-
7917 · PDF RUVBL1和SPARC作为乳腺癌的预后生物标志物 RUVBL1 and SPARC as prognostic biomarkers in breast cancer Flavia Rotea Mangone, Fernando A. Soares, Maria Aparecida Nagai
-
7918 · PDF 抑制MAGED1增加BRCA突变乳腺癌细胞对PARP抑制剂的敏感性 Suppression of MAGED1 increases sensitivity to PARP inhibitor in BRCA-mutated breast cancer cells In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Ho Yong Park, Joon Suk Moon, Ji-Young Park, Yee Soo Chae, Eun Ae Kim, Seol-Hwa Jeong, Jieun Kang
- 7919 7919 高LGR5表达的肺鳞状细胞癌的临床、基因组和治疗结局:一项来自LC-SCRUM-Asia数据库的研究 Clinical, genomic, and therapeutic outcomes of lung squamous cell carcinoma with high LGR5 expression : A study from the LC-SCRUM-Asia database Yu Tanaka, Shuji Murakami, Kazumi Nishino, Motoko Tachihara, Ichiro Nakachi, Mayu Kawakami, Satoshi Hara, hitomi Aono, Shoichi Kuyama, Gaku Yamamoto, Eri Sugiyama, Tetsuya Sakai, Hiroki Izumi, Shigeki Umemura, HIBIKI UDAGAWA, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
-
7920 · PDF 整合蛋白质基因组学揭示HER2阳性乳腺癌中超越HER2 IHC的复发分子预测因子 Integrated proteogenomics reveals molecular predictors of recurrence beyond HER2 IHC in HER2-positive breast cancer Eunjoo Lee, Seung Min Park, Kyung-Hee Kim, So-Youn Jung, Gi Yeon Lee, Eun-Gyeong Lee, Min-Chae Kang, Jong Bae Park, Kong Sun-Young
-
7921 · PDF 复发性KIT突变型胃肠道间质瘤(GIST)中一种新型PDGFRA耐药突变的发生 The development of a novel PDGFRA resistance mutation in a recurrent KIT -mutant gastrointestinal stromal tumor (GIST) Rachael S. Lowney, Shruthi R. Perati, Aaron Dinerman, Abraham Hakim, Molly A. Sullivan, Stephanie N. Canady, Diane S. Ahn, Michael C. Heinrich, Homma Khosroyani, Andrew M. Blakely
-
7922 · PDF 含或不含化疗药物的等离子体活化培养基对正常及恶性人乳腺细胞活力的影响 Effect of plasma activated media, with and without chemotherapeutics, on viability of normal and malignant human breast cells Jakob Doster, Lavanya Sankaran, Chuanling Xu, Nathalie Gonce, Valentyne Thomas, Sofia Melendrez, Komal Vig, Vijay Rangarari, Satyanarayana Pondugula, Amit Morey